Simple and Accurate HPTLC-Densitometric Method for Quantification of Delafloxacin (A Novel Fluoroquinolone Antibiotic) in Plasma Samples: Application to Pharmacokinetic Study in Rats

作者: Prawez Alam , Muzaffar Iqbal , Essam Ezzeldin , Nasr Y. Khalil , Ahmed I. Foudah

DOI: 10.3390/ANTIBIOTICS9030134

关键词:

摘要: Delafloxacin (DLX) is a recently-approved fluoroquinolone antibiotic, which recommended for the treatment of "acute bacterial skin and structure infections". A thorough literature survey revealed only single published method estimation DLX using UPLC-MS/MS technique in biological samples. There no high-performance thin-layer chromatography (HPTLC) has been reported dosage forms and/or Therefore, selective, sensitive, rapid validated HPTLC-densitometry used human plasma first time. HPTLC quantification internal standard (IS; gatifloxacin) was carried out on glass coated silica gel 60 F254 plates ternary mixture ethyl acetate:methanol:ammonia solution 5:4:2 (%, v/v/v) as mobile phase. Densitometric detection done at 344 nm. The Rf values were recorded 0.43 0.27 IS, respectively. linearity range obtained 16-400 ng/band. simple protein precipitation extraction analyte from methanol. proposed "linearity, accuracy, precision, robustness". successfully utilized assessment pharmacokinetic profile rats after oral administration. After administration, peak concentration 194.19 ng/ml 1 h. could be applied study therapeutic drug monitoring clinical practice.

参考文章(20)
Hind T. Hatoum, Kasem S. Akhras, Swu-Jane Lin, The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study. Diagnostic Microbiology and Infectious Disease. ,vol. 64, pp. 305- 310 ,(2009) , 10.1016/J.DIAGMICROBIO.2009.02.005
W.M. El-Koussi, N.N. Atia, A.M. Mahmoud, S.R. El-Shabouri, HPTLC method for direct determination of gemifloxacin mesylate in human plasma Journal of Chromatography B. ,vol. 967, pp. 98- 101 ,(2014) , 10.1016/J.JCHROMB.2014.07.004
Muzaffar Iqbal, Essam Ezzeldin, Khalid A. Al-Rashood, Yousif A. Asiri, Naser L. Rezk, Rapid determination of canagliflozin in rat plasma by UHPLC–MS/MS using negative ionization mode to avoid adduct-ions formation Talanta. ,vol. 132, pp. 29- 36 ,(2015) , 10.1016/J.TALANTA.2014.08.041
P. Kardas, Patient compliance with antibiotic treatment for respiratory tract infections Journal of Antimicrobial Chemotherapy. ,vol. 49, pp. 897- 903 ,(2002) , 10.1093/JAC/DKF046
Matteo Bassetti, Paola Della Siega, Davide Pecori, Claudio Scarparo, Elda Righi, Delafloxacin for the treatment of respiratory and skin infections Expert Opinion on Investigational Drugs. ,vol. 24, pp. 433- 442 ,(2015) , 10.1517/13543784.2015.1005205
Randall Hoover, Thomas Hunt, Michael Benedict, Susan K. Paulson, Laura Lawrence, Sue Cammarata, Eugene Sun, Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age Clinical Therapeutics. ,vol. 38, pp. 39- 52 ,(2016) , 10.1016/J.CLINTHERA.2015.10.016
Marco Falcone, Ercole Concia, Massimo Giusti, Antonino Mazzone, Claudio Santini, Stefania Stefani, Francesco Violi, Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs Internal and Emergency Medicine. ,vol. 11, pp. 637- 648 ,(2016) , 10.1007/S11739-016-1450-6
Abrar K. Thabit, Jared L. Crandon, David P. Nicolau, Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens. International Journal of Antimicrobial Agents. ,vol. 48, pp. 535- 541 ,(2016) , 10.1016/J.IJANTIMICAG.2016.08.012
Anthony Markham, Delafloxacin: First Global Approval. Drugs. ,vol. 77, pp. 1481- 1486 ,(2017) , 10.1007/S40265-017-0790-5